U.S., Feb. 18 -- An application to own the trademark for 'QUBLINTRO' has been filed on Jun. 11, 2025.
Owner(s):
Amgen Inc.; One Amgen Center Drive, Trademark Operations MS-28-5A, CALIFORNIA
Goods and/or Services:
For: Pharmaceutical preparations used for the treatment of cancer and immune diseases and conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of lupus erythematosus, rheumatoid arthritis, multiple sclerosis, neuromyelitis optica and systemic sclerosis
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-02-17&serialNumber=99228721
Disclaimer: Curated by HT Syndication...